Prevalence and Expression of Genes of Type II Antitoxin Toxin Systems in Clinical Isolates of Methicillin-Resistant Staphylococcus aureus

被引:0
|
作者
Rahimkhani, M. [1 ]
Mordadi, A. [2 ]
Karami, P. [3 ]
Zarei, O. [3 ]
机构
[1] Univ Tehran Med Sci, Fac Allied Med Sci, Dept Lab Med Sci, Tehran, Iran
[2] Pasteur Inst, Dept Epidemiol, Tehran, Iran
[3] Hamadan Univ Med Sci, Dept Med Microbiol, Fac Med, Hamadan, Hamadan, Iran
关键词
Staphylococcus; MRSA; Antitoxin-toxin system; MazEF; BIOFILM; DEATH;
D O I
10.9734/JPRI/2021/v33i41A32307
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: Antibiotic resistance of bacteria has been increasing in recent years and reports indicate that some bacterial strains are even resistant to the last treatment line. The survey of MazEF antitoxin-toxin genes in 84 strain of MRSA and and the antimicrobial effect of supernatants on the logarithmic growth stage of the bacteria. Methods: In this study, 84 strains of MRSA were collected. The patients included 48 males and 36 females with a mean age of 39 years. The primers for Staphylococcus aureus type II antitoxin genes were designed. In the first step, using the mecA primer and PCR, the strains were genetically examined to confirm methicillin-resistant Staphylococcus aureus. In the next step, the frequency of MazEF antitoxin-toxin genes was examined. Results: All strains of methicillin-resistant Staphylococcus aureus had the F maz gene except one. The highest antibiotic resistance was related to the strains isolated from the wound and the lowest resistance was related to the strains isolated from the urine. the effect of the supernatant obtained in the death phase of Staphylococcus aureus was assessed and the antimicrobial effect of these supernatants on the logarithmic growth stage of the bacteria was measured. Conclusion: since previous studies showed the antimicrobial effect of this supernatant on many other bacteria, a type II system was suspected that was confirmed by the results.
引用
收藏
页码:96 / 105
页数:10
相关论文
共 50 条
  • [31] Molecular Characterization of Clinical Methicillin-Resistant Staphylococcus aureus Isolates in South Africa
    Moodley, A.
    Oosthuysen, W. F.
    Duse, A. G.
    Marais, E.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (12) : 4608 - 4611
  • [32] Surveillance for Mupirocin Resistance Among Methicillin-Resistant Staphylococcus aureus Clinical Isolates
    Mongkolrattanothai, Kanokporn
    Mankin, Peggy
    Raju, Venkedesh
    Gray, Barry
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (10): : 993 - 994
  • [33] Draft Genome Sequences of Two Methicillin-Resistant Clinical Staphylococcus aureus Isolates
    Khan, Saeed
    Sung, Kidon
    Iram, Saira
    Nawaz, Mohamed
    Xu, Joshua
    Marasa, Bernard
    GENOME ANNOUNCEMENTS, 2016, 4 (01)
  • [34] Phenotypic Detection of Biofilm Formation in Clinical Isolates of Methicillin-Resistant Staphylococcus aureus
    Malik, Nitisha
    Bisht, Dakshina
    Aggarwal, Juhi
    Rawat, Ashutosh
    ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE, 2022, 14 (01) : 43 - 47
  • [35] Spectrum of Virulence Factors in Clinical Isolates of Staphylococcus aureus and Prevalence of SCCmec Types in Methicillin-Resistant Staphylococcus aureus in a Tertiary Care Center
    Khodabux, Rhea Michelle J.
    Mariappan, Shanthi
    Sekar, Uma
    JOURNAL OF LABORATORY PHYSICIANS, 2023, 15 (03) : 450 - 461
  • [36] PREVALENCE AND ANTIMICROBIAL PROFILE OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
    Osmalli, Damiana
    Simaku, Artan
    INTERNATIONAL JOURNAL OF ECOSYSTEMS AND ECOLOGY SCIENCE-IJEES, 2015, 5 (01): : 123 - 128
  • [37] THE WORLDWIDE PREVALENCE OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    VOSS, A
    DOEBBELING, BN
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1995, 5 (02) : 101 - 106
  • [38] Prevalence of toxin genes in consecutive clinical isolates of Staphylococcus aureus and clinical impact
    Nhan, T. -X.
    Leclercq, R.
    Cattoir, V.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (06) : 719 - 725
  • [39] PATTERNS OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS PREVALENCE
    BOYCE, JM
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1991, 12 (02): : 79 - 82
  • [40] Prevalence of toxin genes in consecutive clinical isolates of Staphylococcus aureus and clinical impact
    T.-X. Nhan
    R. Leclercq
    V. Cattoir
    European Journal of Clinical Microbiology & Infectious Diseases, 2011, 30 : 719 - 725